Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern Sells 3,609 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) VP Paul L. Alpern sold 3,609 shares of the business’s stock in a transaction on Friday, April 4th. The shares were sold at an average price of $6.03, for a total transaction of $21,762.27. Following the transaction, the vice president now owns 83,717 shares of the company’s stock, valued at $504,813.51. This represents a 4.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Arteris Stock Performance

AIP traded down $0.61 on Friday, reaching $5.99. The stock had a trading volume of 225,185 shares, compared to its average volume of 195,798. The business’s 50-day moving average price is $8.70 and its two-hundred day moving average price is $8.78. The company has a market cap of $245.28 million, a P/E ratio of -6.88 and a beta of 1.21. Arteris, Inc. has a 12-month low of $5.76 and a 12-month high of $12.64. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30.

Arteris (NASDAQ:AIPGet Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The business had revenue of $15.49 million during the quarter, compared to analysts’ expectations of $15.34 million. Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. Sell-side analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in AIP. US Bancorp DE increased its holdings in Arteris by 29.0% in the 4th quarter. US Bancorp DE now owns 5,702 shares of the company’s stock worth $58,000 after acquiring an additional 1,283 shares in the last quarter. American Century Companies Inc. increased its stake in shares of Arteris by 6.0% during the fourth quarter. American Century Companies Inc. now owns 30,357 shares of the company’s stock worth $309,000 after purchasing an additional 1,731 shares in the last quarter. EntryPoint Capital LLC raised its position in shares of Arteris by 14.0% during the 4th quarter. EntryPoint Capital LLC now owns 19,814 shares of the company’s stock worth $202,000 after purchasing an additional 2,430 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Arteris by 4.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company’s stock valued at $802,000 after buying an additional 3,298 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its stake in Arteris by 38.9% in the 4th quarter. Wells Fargo & Company MN now owns 13,192 shares of the company’s stock valued at $134,000 after buying an additional 3,694 shares in the last quarter. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on AIP shares. Northland Securities lifted their price objective on Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Wednesday, February 19th. Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Tuesday, February 18th.

Get Our Latest Report on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Further Reading

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.